DSGN·25056L103·US·equity·Healthcare - Biotechnology-Activist
DSGN (DESIGN THERAPEUTICS INC) is held by 74 institutional investors as of Q4 2025. Largest holders: Point72 Asset Management, L.P. ($50.4M), BAKER BROS. ADVISORS LP ($20.9M), BlackRock, Inc. ($19.9M). Net institutional sentiment: Bullish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer